Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 23 of 100
Health
‘It felt like we were talking to statues’: An OxyContin addict who confronted the Sackler family about opioids reveals their stoicism
By
Carmela Chirinos
March 16, 2022
International
Europeans are so scared of a nuclear attack they’re panic buying iodine tablets
By
Christiaan Hetzner
March 8, 2022
Commentary
Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
By
Andrei Iancu
,
David J. Kappos
and
Paul R. Michel
March 4, 2022
Commentary
Pharma’s sense of urgency must outlast the pandemic
By
Paul Hudson
February 22, 2022
Health
Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug
By
Arthur Allen
and
Kaiser Health News
February 16, 2022
Commentary
Democrats must get their act together, starting with drug prices
By
Howard Dean
February 3, 2022
Commentary
Inequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
By
Jennifer Lotito
January 31, 2022
Health
There’s a silent epidemic killing over 100,000 Americans a year, and the government is allowing the cure to get more and more expensive
By
Andrew Marquardt
January 31, 2022
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By
Jeremy Kahn
and
Jonathan Vanian
January 25, 2022
International
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
By
Christiaan Hetzner
January 21, 2022
Health
Mark Cuban opens his own online pharmacy
By
Chris Morris
January 20, 2022
Health
Medicare ordered to reassess premium hike for Alzheimer’s drug
By
Ricardo Alonso-Zaldivar
and
The Associated Press
January 10, 2022
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By
Jeremy Kahn
January 7, 2022
Commentary
World leaders should acknowledge that IP protections facilitate vaccine access
By
Andrei Iancu
December 24, 2021
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
By
Suzi Ring
and
Bloomberg
December 23, 2021
Most Popular
Success
MacKenzie Scott gifts $80 million to Howard University, marking one of the school’s largest donations in its 158-year...
By
Sydney Lake
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use...
By
Preston Fore
Economy
Trump’s former trade architect says the president can’t backtrack on tariffs because he’s ‘too committed’ now: ‘That...
By
Eva Roytburg